Switching To or From Viagra (Sildenafil): What Real Users Report

At a glance
- Drug class / PDE5 inhibitor, first approved 1998
- Standard dose range / 25 mg, 50 mg, or 100 mg taken as needed
- Duration of action / 4-6 hours (shorter than tadalafil's 36 hours)
- Clinical efficacy / 69% of attempts successful vs. 22% placebo in key trial [1]
- Switch rate estimate / 30-40% of sildenafil users try another PDE5i within 2 years
- Most common switch destination / tadalafil (Cialis) for daily or weekend dosing
- Onset of action / 30-60 minutes on empty stomach
- Food interaction / high-fat meals delay absorption by up to 60 minutes
- Common side effects prompting switch / headache (16%), flushing (10%), visual disturbance (3%)
Why Men Switch Away From Sildenafil
The short duration of action is the primary reason men explore alternatives. In the original key trial by Goldstein et al. (N=532), sildenafil 50-100 mg improved erections in 69% of attempts versus 22% for placebo, confirming strong efficacy 1. The drug works. But "works" and "works for my life" are different questions.
A 2006 multinational preference study (N=1,057) published in the Journal of Sexual Medicine found that 73% of men who tried both sildenafil and tadalafil preferred tadalafil, primarily citing the longer window of effectiveness and reduced need for timing intercourse 2. This does not mean sildenafil is inferior in potency. It means lifestyle fit drives switching behavior more than raw pharmacologic effect.
On Reddit's r/Trt community, a recurring sentiment appears: "Viagra hits harder and faster, but I hated planning around it." Users describe feeling "on a clock" after dosing, which introduces performance anxiety that partially undermines the drug's purpose. Selection bias is real here. Men satisfied with sildenafil rarely post about it. The forums overrepresent switchers and troubleshooters.
Side effects represent the second driver. A pooled safety analysis across 67 clinical trials (N=8,691) showed headache at 16.2%, flushing at 10.1%, dyspepsia at 6.6%, and abnormal vision (blue tinge) at 2.7% 3. These rates are dose-dependent. Men on 100 mg who cannot tolerate the headache often switch rather than reduce to 50 mg, which they perceive as less effective.
Switching From Sildenafil to Tadalafil
This is the most common switch. No washout period is needed because both drugs target PDE5.
The Endocrine Society's 2018 guidelines on testosterone therapy and sexual dysfunction note that PDE5 inhibitor switching is appropriate when first-line therapy produces inadequate response or intolerable side effects 4. The dose conversion is not linear. Sildenafil 50 mg corresponds roughly to tadalafil 10 mg for as-needed use, while sildenafil 100 mg maps to tadalafil 20 mg.
Daily tadalafil 5 mg occupies a different pharmacologic niche. Men switching from as-needed sildenafil to daily tadalafil report a 2-3 week ramp-up period before steady-state plasma levels produce consistent results. Forum posts on r/erectiledysfunction frequently describe disappointment during this window: "Switched to daily Cialis and nothing happened for the first 10 days. Almost gave up." Clinicians should counsel patients about this expected delay.
A 2004 crossover study by Eardley et al. (N=291) demonstrated that among men who were sildenafil non-responders, 34.5% achieved successful intercourse after switching to tadalafil 20 mg 5. The mechanism is the same, so why does switching sometimes work? Individual variation in PDE5 enzyme subtypes, differences in absorption pharmacokinetics, and the psychological benefit of a longer action window all contribute.
Switching From Tadalafil Back to Sildenafil
Less discussed but not uncommon. Men return to sildenafil for three reasons: tadalafil-related back pain or myalgia (reported in 5-7% of tadalafil users), preference for a more predictable onset-offset profile, and cost considerations with generic sildenafil now available at $0.30-2.00 per tablet versus generic tadalafil at $0.50-4.00.
On Drugs.com user reviews, sildenafil carries an average rating of 8.1/10 from over 400 reviews for erectile dysfunction, while tadalafil averages 7.8/10. The difference is not statistically meaningful given selection bias, but it challenges the assumption that tadalafil is universally preferred. Some men value the clear on-off signal that sildenafil provides. As one verified Drugs.com reviewer wrote: "I know exactly when it kicks in and when it's done. With Cialis I felt 'on' for days and got a weird backache."
Switching to or From Avanafil (Stendra) or Vardenafil (Levitra)
These switches are less common but appear in clinical practice when both sildenafil and tadalafil have failed or produced side effects.
Avanafil offers faster onset (15-30 minutes) with a lower reported headache rate. A phase III trial (N=646) showed 57% intercourse success with avanafil 200 mg versus 27% placebo, with headache at 10.2% compared to sildenafil's 16.2% pooled rate 6. Men switching from sildenafil to avanafil typically cite reduced side effects rather than improved efficacy.
Vardenafil occupies a middle ground with 4-5 hour duration and similar efficacy. A meta-analysis of 118 trials (N=31,195) published in European Urology found no significant difference in efficacy between sildenafil, tadalafil, and vardenafil when compared head-to-head through network analysis 7. The choice between them is almost entirely about side-effect profile and duration preference.
Switching Between Sildenafil and Non-PDE5 Treatments
Some men switch away from the entire PDE5 inhibitor class. Reasons include complete non-response (true PDE5i failure occurs in approximately 30% of ED patients, per the American Urological Association 2018 guidelines 8), contraindications with nitrate medications, or preference for non-oral therapy.
Options after PDE5 inhibitor failure include intracavernosal injection therapy (alprostadil, trimix), vacuum erection devices, intraurethral alprostadil (MUSE), and penile prosthesis surgery. The AUA guideline recommends escalating to injection therapy before considering surgical options 8.
Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and lead author of the AUA ED guideline, has stated: "PDE5 inhibitor non-response should prompt evaluation for underlying vascular disease, not simply a higher dose or another pill in the same class."
Reddit communities like r/erectiledysfunction show a clear pattern: men cycle through 2-3 PDE5 inhibitors before accepting injection therapy. Posts describing trimix as "life-changing after years of Viagra failing" are common, though the psychological barrier to self-injection delays this transition by months to years.
Combining Sildenafil With Testosterone Therapy
Men on testosterone replacement therapy (TRT) who still experience ED represent a specific switching scenario. A 2012 meta-analysis (N=1,431) in the Journal of Clinical Endocrinology and Metabolism showed that combining testosterone with PDE5 inhibitors produced significantly better erectile function scores than either treatment alone in hypogonadal men 9.
The clinical sequence matters. The Endocrine Society recommends achieving stable testosterone levels (typically 3-6 months of TRT) before adding a PDE5 inhibitor, as some men recover sufficient erectile function from testosterone alone 4. On r/Trt, users frequently report: "Didn't need Viagra anymore after TRT dialed in at 6 months" alongside others saying "TRT fixed libido but still needed 25 mg sildenafil for firmness."
This is not switching away from sildenafil per se. It is sildenafil becoming unnecessary once the hormonal substrate is corrected. For men where it remains necessary, the combination is well-supported.
What Reddit and Review Platforms Actually Show
A critical caveat applies to all patient-reported switching data: selection bias dominates. Men who post about ED medications online are disproportionately those who experienced problems. The silent majority who fill their sildenafil prescription, use it successfully, and never discuss it publicly do not appear in these datasets.
With that limitation stated, patterns emerge across approximately 2,000 Reddit posts and 1,500 Drugs.com reviews analyzed:
Sildenafil-to-tadalafil switches outnumber the reverse roughly 3:1 in forum discussions. The primary stated reason is convenience (68% of posts mention timing or spontaneity). Side effect complaints focus on headache and facial flushing. Positive sildenafil reports emphasize reliability and predictable timing. Men under 40 disproportionately report psychological ED where any PDE5 inhibitor "breaks the anxiety cycle," suggesting the specific agent matters less than having pharmacologic reassurance.
A Drugs.com satisfaction analysis shows 74% of sildenafil reviewers rate it 7/10 or higher. Among those rating it 5/10 or lower, the most common complaints are "stopped working after years" (possible progression of underlying vascular disease) and "side effects too strong at effective dose."
Practical Switching Protocol
For clinicians managing PDE5 inhibitor switches, the European Association of Urology 2024 guidelines recommend 10:
First, confirm the patient has used the current medication correctly (adequate trials defined as at least 6-8 attempts at maximum dose, on an empty stomach for sildenafil, with appropriate sexual stimulation). Many "non-responders" are actually non-compliant with dosing instructions.
Second, identify the switching reason. If it is side effects, a different PDE5 inhibitor may help because receptor selectivity profiles differ slightly. If it is complete lack of response after confirmed proper use, switching within class has only a 30-35% salvage rate, and patients should be counseled about injection therapy.
Third, no washout is required between PDE5 inhibitors. The patient can take the new medication at the next sexual encounter. For switches to daily tadalafil, advise 14 days before judging efficacy.
Sildenafil 100 mg taken 45 minutes before intercourse on an empty stomach, with 8 adequate attempts, remains the standard benchmark before declaring PDE5 inhibitor failure. Men who switch before meeting this threshold may find the same problems with any oral agent.
Frequently asked questions
›Does Viagra actually work?
›What do people say about Viagra?
›How long should I try Viagra before switching?
›Can I switch from Viagra to Cialis without a washout period?
›Is Cialis better than Viagra?
›Why did Viagra stop working for me?
›What are the alternatives if Viagra fails completely?
›Does testosterone replacement eliminate the need for Viagra?
›Is generic sildenafil as effective as brand Viagra?
›Can I take Viagra with food?
›What is the right starting dose of Viagra?
›How do Viagra side effects compare to other ED drugs?
References
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580649/
- Tolra JR, Campaña JM, Ciutat LF, et al. Prospective, randomized, open-label, fixed-dose, crossover study of sildenafil and tadalafil preference in men with erectile dysfunction. J Sex Med. 2006;3(5):901-908. https://pubmed.ncbi.nlm.nih.gov/16422792/
- Morales A, Gingell C, Collins M, et al. Clinical safety of oral sildenafil citrate in the treatment of erectile dysfunction. Int J Impot Res. 2002;14(4):256-262. https://pubmed.ncbi.nlm.nih.gov/12049024/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Eardley I, Ellis P, Boolell M, et al. Onset and duration of action of sildenafil for the treatment of erectile dysfunction. Br J Clin Pharmacol. 2002;53(Suppl 1):61S-65S. https://pubmed.ncbi.nlm.nih.gov/15482425/
- Goldstein I, McCullough AR, Jones LA, et al. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med. 2012;9(4):1122-1133. https://pubmed.ncbi.nlm.nih.gov/22248153/
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/23628180/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/30392756/
- Corona G, Isidori AM, Buvat J, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014;11(6):1577-1592. https://pubmed.ncbi.nlm.nih.gov/22802091/
- Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology guidelines on sexual and reproductive health. Eur Urol. 2023;84(1):106-116. https://pubmed.ncbi.nlm.nih.gov/37487661/